The European Medicine’s Agency is expected to approve Pfizer’s vaccine at an extraordinary meeting on 21 December and then, within three days, the European Commission is set to give its final green light. As for the vaccination process, in practice, everything depends on the readiness of EU countries, especially when it comes to logistics.